Home / Added value of concomitant systematic biopsies in predicting upgrading in patients with localized prostate cancer diagnosed by MRI-targeted biopsy: Implications for treatment selection
Added value of concomitant systematic biopsies in predicting upgrading in patients with localized prostate cancer diagnosed by MRI-targeted biopsy: Implications for treatment selection
Gandaglia G. 1,
Ploussard G. 2,
Valerio M. 3,
Mattei A. 4,
Fiori C. 5,
Fossati N. 1,
Stabile A. 1,
Beauval J. 6,
Malavaud B. 6,
Roumiguié M. 6,
Robesti D. 1,
Dell’Oglio P. 1,
Dehò F. 1,
Capitanio U. 1,
Moschini M. 4,
Zamboni S. 4,
Rakauskas A. 3,
De Cobelli F. 7,
Porpiglia F. 5,
Montorsi F. 1,
Briganti A. 1
1
IRCCS Ospedale San Raffaele, Unit of Urology, Division of Oncology, Milan, Italy 2
Saint Jean Languedoc/La Croix du Sud Hospital, Dept. of Urology, Toulouse, France 3
Centre Hospitalier Universitaire Vaudois, Dept. of Urology, Lausanne, Switzerland 4
Luzerner Kantonsspital, Dept. of Urology, Lucerne, Switzerland 5
San Luigi Gonzaga Hospital, Dept. of Urology, Turin, Italy 6
CHU Rangueil, Dept. of Urology, Andrology and Renal Transplantation,, Toulouse, France 7
IRCCS Ospedale San Raffaele, Unit of Clinical Research in Radiology, Experimental Imaging Center, Milan, Italy